MelissaMary(Thrall)HardestyMDMPH

PubMed

• Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion.
  Olivia G Beck, Melissa M Hardesty> ;Gynecologic Oncology Reports. 2023 Jun 1
• 19 citations
  OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with be...
  Melissa M Hardesty, Thomas C Krivak, Gail S Wright, Erika Hamilton, Evelyn L Fleming, Jimmy Belotte, Erika K Keeton, Ping Wang, Divya Gupta, Aine Clements, Heidi J Gra...> ;Gynecologic Oncology. 2022 Aug 1
• 32 citations
  A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer.
  Morgan Burke, Melissa Hardesty, Wayne Downs> ;Gynecologic Oncology Reports. 2018 Mar 26
• 15 citations
  The end of life costs for Medicare patients with advanced ovarian cancer
  Renata R. Urban, Hao He, Raphael Alfonso, Melissa M. Hardesty, Barbara A. Goff> ;Gynecologic Oncology. 2017 Dec 1
• 3 citations
  Conservative Management of Invasive Placentation: Two Cases with Different Surgical Approaches.
  Emily E. Fay, Barbara M. Norquist, Jennifer Jolley, Melissa Hardesty> ;AJP Reports. 2016 Apr 1
• 30 citations
  The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer
  Renata R. Urban, Hao He, Rafael Alfonso-Cristancho, Melissa M. Hardesty, Barbara A. Goff> ;Journal of the National Comprehensive Cancer Network. 2016 Apr 1
• 39 citations
  Ovarian cancer outcomes: Predictors of early death.
  Renata R. Urban, Hao He, Raphael Alfonso, Melissa M. Hardesty, Heidi J. Gray, Barbara A. Goff> ;Gynecologic Oncology. 2016 Mar 1
• BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
  Lesnock, J. L.,Darcy, K. M.,Tian, C.,Deloia, J. A.,Thrall, M. M.,Zahn, C.,Armstrong, D. K.,Birrer, M. J.,Krivak, T. C.> ;Br. J. Cancer. 2013 Apr 2
• Letter-to-the Editor "Trends in treatment of advanced epithelial ovarian cancer in the Medicare population"
  Thrall, M.M., Gray, H.J., Goff, B.A.> ;Gynecol Oncol. 2012-01-05
• Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer.
  Thrall, M.M., Gray, H.J., Symons, R.G., Weiss, N.S., Flum, D.R., Goff, B.A.> ;Gynecol Oncol. 2011 Dec
• Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly.
  Thrall, M.M., Goff, B.A., Symons, R.G., Flum, D.R., Gray, H.J.> ;Obstet Gynecol. 2011 Sep
• Pagetoid adenocarcinoma in situ of the cervix with pagetoid spread into the vagina.
  Mahdi, H., Thrall, M., Agoff, N., Doherty, M.> ;Obstet Gynecol. 2011 Aug
• The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients.
  Mahdi, H., Thrall, M., Kumar, S., Hanna, R., Seward, S., Lockhart, D., Morris, R. T., Swensen, R., Munkarah, A. R.> ;J Surg Oncol. 2011 Jun 1
• Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.
  Thrall, M.M., Gray, H.J., Symons, R.G., Weiss, N.S., Flum, D.R., Goff, B.A.> ;Gynecol Oncol. 2011 Jul
• Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.
  Thrall, M.M., Paley, P., Pizer, E., Garcia, R., Goff, B.A.> ;Gynecol Oncol. 2011 Aug
• Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
  Thrall, M.M., DeLoia, J.A., Gallion, H., Avril, N.> ;Gynecol Oncol. 2007 Apr
• Expectant management of intramural ectopic pregnancy.
  Bernstein, H. B., Thrall, M. M., Clark, W. B.> ;Obstet Gynecol. 2001 May
• Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced re...
  Thrall, M. M., Wood, P., King, V., Rivera, W., Hrushesky, W.> ;Int J Radiat Oncol Biol Phys. 2000 Mar 1
• Join now to see all